SCHEMBL2444590

SCHEMBL2444590

N#CC1CNCCO1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL17376469 0.98
Butadiene SCHEMBL28309598 0.89
SCHEMBL17673086 0.80
SCHEMBL7319 0.78
SCHEMBL5265334 0.78
SCHEMBL5786863 0.78
SCHEMBL25658774 0.78
SCHEMBL1776559 0.78
SCHEMBL20017843 0.78
SCHEMBL3263836 0.78

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 96 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4724442-A1 AGONISM-ANTAGONISM IN ENDOSOMAL TLRS BY MODULATING CHEMICAL FEATURES IN 8-OXOPURINE: PROCESS FOR PREPARATION AND APPLICATION THEREOF Council of Scientific and Industrial Research (IN) 2026-04-15 EP claimed
EP-3528813-B1 P2X3 AND/OR P2X2/3 COMPOUNDS AND METHODS ABS DEV 1 INC (US) 2025-04-16 EP claimed
EP-3697410-B1 BENZIMIDAZOLE DERIVATIVES AND THEIR USES TEIJIN PHARMA LTD (JP) 2024-12-18 EP claimed
CN-111225916-B Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders 加拉帕戈斯股份有限公司 2023-11-03 CN claimed
US-20130040934-A1 SPIROCYCLIC COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS AND DIAGNOSTIC PROBES UNIVERSITY OF BASEL (CH) 2013-02-14 US claimed
EP-2547684-A1 SPIROCYCLIC COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS AND DIAGNOSTIC PROBES University of Basel (CH) 2013-01-23 EP claimed
WO-2011114275-A1 SPIROCYCLIC COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS AND DIAGNOSTIC PROBES UNIVERSITY OF BASEL (CH) 2011-09-22 WO claimed
EP-0441218-A2 Anthracycline-glycosyl prodrugs, process for their preparation and their use in combination with functionalised tumour-specific enzyme conjugates BEHRINGWERKE Aktiengesellschaft (DE) 1991-08-14 EP claimed
EP-4724442-A1 AGONISM-ANTAGONISM IN ENDOSOMAL TLRS BY MODULATING CHEMICAL FEATURES IN 8-OXOPURINE: PROCESS FOR PREPARATION AND APPLICATION THEREOF Council of Scientific and Industrial Research (IN) 2026-04-15 EP disclosed
US-12545675-B2 Anti-wolbachia pyrido[2,3-d]pyrimidine compounds LIVERPOOL SCHOOL OF TROPICAL MEDICINE (GB) 2026-02-10 US disclosed
US-20250388468-A1 METHOD FOR PRODUCING SULFIDE SOLID ELECTROLYTE IDEMITSU KOSAN CO.,LTD. (JP) 2025-12-25 US disclosed
EP-4553862-A1 METHOD FOR PRODUCING SULFIDE SOLID ELECTROLYTE Idemitsu Kosan Co.,Ltd. (JP) 2025-05-14 EP disclosed
EP-4553860-A1 METHOD FOR PRODUCING SULFIDE SOLID ELECTROLYTE Idemitsu Kosan Co.,Ltd. (JP) 2025-05-14 EP disclosed
CN-119487586-A Method for producing sulfide solid electrolyte 出光兴产株式会社 2025-02-18 CN disclosed
EP-0441218-A2 Anthracycline-glycosyl prodrugs, process for their preparation and their use in combination with functionalised tumour-specific enzyme conjugates BEHRINGWERKE Aktiengesellschaft (DE) 1991-08-14 EP disclosed
EP-0441218-A2 Anthracycline-glycosyl prodrugs, process for their preparation and their use in combination with functionalised tumour-specific enzyme conjugates BEHRINGWERKE Aktiengesellschaft (DE) 1991-08-14 EP disclosed
US-4883874-A Azabicyclic intermediates BEECHAM GROUP PLC. OF BEECHAM HOUSE (GB) 1989-11-28 US disclosed
US-4826839-A GASTROINTESTINAL DISORDERS, HEADACHES BEECHAM GROUP P.L.C. (GB) 1989-05-02 US disclosed
EP-0226267-A1 Oxa-, thia- and diazabicycloalkane derivatives, process for their preparation and their use as pharmaceuticals BEECHAM GROUP PLC (GB) 1987-06-24 EP disclosed
US-4098791-A Process for preparing 3-(cyanimino)-3-amino-propionitriles THE UPJOHN COMPANY (US) 1978-07-04 US disclosed